sulforaphane has been researched along with Ciliary Motility Disorders in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Ciliary Motility Disorders: Conditions caused by abnormal CILIA movement in the body, usually causing KARTAGENER SYNDROME, chronic respiratory disorders, chronic SINUSITIS, and chronic OTITIS. Abnormal ciliary beating is likely due to defects in any of the 200 plus ciliary proteins, such as missing motor enzyme DYNEIN arms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YP | 1 |
| Tsai, IC | 1 |
| Morleo, M | 1 |
| Oh, EC | 1 |
| Leitch, CC | 1 |
| Massa, F | 1 |
| Lee, BH | 1 |
| Parker, DS | 1 |
| Finley, D | 1 |
| Zaghloul, NA | 1 |
| Franco, B | 1 |
| Katsanis, N | 1 |
1 other study available for sulforaphane and Ciliary Motility Disorders
| Article | Year |
|---|---|
Ciliopathy proteins regulate paracrine signaling by modulating proteasomal degradation of mediators.
Topics: Animals; Anticarcinogenic Agents; Cell Line; Ciliary Motility Disorders; Humans; I-kappa B Proteins; | 2014 |